Brief: Citius Oncology Signs U.S. Distribution Agreement With Mckesson To Support Lymphir Commercial Launch
20/10/2025 13:44
Oct 20 (Reuters) - Citius Oncology Inc CTOR.O: CITIUS ONCOLOGY SIGNS U.S. DISTRIBUTION AGREEMENT WITH MCKESSON TO SUPPORT LYMPHIR™ COMMERCIAL LAUNCH CITIUS ONCOLOGY INC - LYMPHIR COMMERCIAL LAUNCH PLANNED FOR Q4 2025 Source text: ID:nPn15xXh8a Further company coverage: CTOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Oncology
See all newsCitius Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Citius Oncology Inc expected to post a loss of 5 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-AnaptysBio, Tesla, Intel
U.S. STOCKS ON THE MOVE-Dycom Industries, Robinhood, Brown-Forman
Citius rises as lymphoma drug shows benefit in patients before CAR-T therapy